Session Abstract – PMWC 2019 Silicon Valley

The PMWC 2019 Genomic Profiling Showcase will take place on January 21, this showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.

Confirmed Presenting Companies:

The PMWC 2019 Genomic Profiling Showcase will take place on January 21, this showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.

Confirmed Presenting Companies:

Session Chair Profile

BSc, M.B.A, Chief Executive Officer, Roche Pharmaceuticals
Biography

Daniel O’Day is the Chief Executive Officer of Roche Pharmaceuticals and has been in his current role since 2012. Prior to that, Daniel was Chief Executive Officer of Roche Diagnostics. His global career spans three decades of diverse leadership roles across North America, Asia Pacific and Europe.After joining Roche Pharmaceuticals in 1987, Daniel held various roles in the U.S before moving to Roche headquarters in Switzerland in 1998. During his time there he held leadership roles in Global Marketing and Lifecycle Management. In 2001, Daniel’s career took him to Tokyo, where he was Head of Corporate Planning for Roche Pharma in Japan and later to Denmark as General Manager. Daniel became President of Roche Molecular Diagnostics in California in 2006 and subsequently returned to Roche headquarters to lead the Diagnostics Division.Daniel holds a Bachelor of Science in Biology from Georgetown University in Washington DC and an MBA from Columbia University in New York.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!